ProCE Banner Activity

Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease

Podcast Episodes
In this podcast episode, Conor Ernst Steuer, MD, a medical oncologist; Frank Schneider, MD, a pathologist; and Elise Hitron, MSN, FNP-C, a phase I clinical trials nurse practitioner, engage in a multidisciplinary discussion of the latest management strategies for EGFR-mutated non-small-cell lung cancer, including the evolving treatment landscape for disease resistant to standard-of-care EGFR TKI inhibitors.

Released: January 26, 2022

Expiration: January 25, 2023

No longer available for credit.

Share

Faculty

Elise Hitron

Elise Hitron, MSN, FNP-C

Nurse Practitioner
Phase I Clinical Trials at Winship Cancer Institute
Atlanta, Georgia

Frank Schneider

Frank Schneider, MD

Associate Professor of Pathology
Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Elise Hitron, MSN, FNP-C

Nurse Practitioner
Phase I Clinical Trials at Winship Cancer Institute
Atlanta, Georgia

Elise Hitron, MSN, FNP-C, has no relevant conflicts of interest to report.

Frank Schneider, MD

Associate Professor of Pathology
Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Atlanta, Georgia

Frank Schneider, MD, has no relevant conflicts of interest to report.